Clinical Trials Browser

Has results × Squamous Cell Non-small Cell Lung Cancer × Nivolumab × Clear all

NCT01642004 2022-12-28

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)

Phase 3 Completed

272 enrolled 23 charts

Squamous Cell Non-small Cell Lung Cancer

NCT01721759 2022-06-28

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Phase 2 Completed

117 enrolled 17 charts

Squamous Cell Non-small Cell Lung Cancer